During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

The sclerotic bone lesions found in patients with ECD can be mistaken for metastatic carcinoma or hematological neoplasms such as plasmocytoma.

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

The following six biosimilars were given a positive opinion at the June meeting: treatments for treatment of age-related macular degeneration and visual impairment: Mynzepli (aflibercept), and its ...

Lancet Oncol 2019 Sep;20 (9):1286-1294. Harmon SA, Mena E, Shih JH, et al. A comparison of prostate cancer bone metastases on 18F-sodium fluoride and prostate specific antigen (18F-PSMA) PET/CT: ...

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Bone and Cancer Working Group has released a comprehensive review detailing the often under-recognized impact of modern ...

A recent discovery could transform our understanding of bone health maintenance and pave the way for potential treatments for ...

During a live event, Fengting Yan, MD, PhD, discussed safety outcomes from the TROPION-Breast01 and supportive care for ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...